• Je něco špatně v tomto záznamu ?

Crushed dolutegravir/abacavir/lamivudine given via nasogastric tube in gastric outlet obstruction caused by cancer resulted in rapid viral load suppression

A. Chrdle, Z. Jerhotová, M. Vacík, M. Linka, V. Chmelík,

. 2019 ; 30 (1) : 94-98. [pub] 20180919

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035013

Alternative modes of antiretroviral administration are sought for people with impaired intestinal passage and/or absorption. We present a case of late HIV diagnosis (CD4+ count 160 cells/µL) with gastric outlet obstruction due to stomach adenocarcinoma. Co-morbidities included oesophageal candidiasis, Helicobacter pylori-positive duodenal ulcers and cytomegalovirus duodenitis. The gastric outlet obstruction required total parenteral nutrition and parenteral medication during four weeks of diagnostic work-up leading to pyloric resection. Crushed dolutegravir, abacavir and lamivudine were administered during this time in the evening via nasogastric tube, which was kept clamped overnight. The tube was unclamped in the morning and stomach content was drained during the daytime. This mode of administration resulted in rapid and sustained viral load suppression (from 300,000 to 115 copies per mL in 28 days, 81 copies/mL after 42 days of treatment and less than 40 copies/mL thereafter). Therapeutic drug monitoring confirmed sufficient antiretroviral plasma levels during this mode of administration. The absorption of crushed dolutegravir, abacavir and lamivudine in the stomach may be considered in people with questionable gastrointestinal passage or impaired gastric emptying to achieve viral load suppression.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035013
003      
CZ-PrNML
005      
20201104105759.0
007      
ta
008      
191007s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/0956462418797847 $2 doi
035    __
$a (PubMed)30231834
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Chrdle, Aleš $7 xx0253541 $u 1 Infectious Diseases Department, České Budějovice Hospital, České Budějovice, Czech Republic. 2 Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool, UK.
245    10
$a Crushed dolutegravir/abacavir/lamivudine given via nasogastric tube in gastric outlet obstruction caused by cancer resulted in rapid viral load suppression / $c A. Chrdle, Z. Jerhotová, M. Vacík, M. Linka, V. Chmelík,
520    9_
$a Alternative modes of antiretroviral administration are sought for people with impaired intestinal passage and/or absorption. We present a case of late HIV diagnosis (CD4+ count 160 cells/µL) with gastric outlet obstruction due to stomach adenocarcinoma. Co-morbidities included oesophageal candidiasis, Helicobacter pylori-positive duodenal ulcers and cytomegalovirus duodenitis. The gastric outlet obstruction required total parenteral nutrition and parenteral medication during four weeks of diagnostic work-up leading to pyloric resection. Crushed dolutegravir, abacavir and lamivudine were administered during this time in the evening via nasogastric tube, which was kept clamped overnight. The tube was unclamped in the morning and stomach content was drained during the daytime. This mode of administration resulted in rapid and sustained viral load suppression (from 300,000 to 115 copies per mL in 28 days, 81 copies/mL after 42 days of treatment and less than 40 copies/mL thereafter). Therapeutic drug monitoring confirmed sufficient antiretroviral plasma levels during this mode of administration. The absorption of crushed dolutegravir, abacavir and lamivudine in the stomach may be considered in people with questionable gastrointestinal passage or impaired gastric emptying to achieve viral load suppression.
650    _2
$a adenokarcinom $x komplikace $7 D000230
650    _2
$a antiretrovirové látky $x terapeutické užití $7 D044966
650    _2
$a dideoxynukleosidy $x aplikace a dávkování $x terapeutické užití $7 D015224
650    _2
$a obstrukce vyprazdňování žaludku $x komplikace $7 D017219
650    _2
$a HIV infekce $x diagnóza $x farmakoterapie $7 D015658
650    _2
$a heterocyklické sloučeniny tricyklické $x aplikace a dávkování $x terapeutické užití $7 D006575
650    _2
$a lidé $7 D006801
650    _2
$a gastrointestinální intubace $7 D007441
650    _2
$a lamivudin $x aplikace a dávkování $x terapeutické užití $7 D019259
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a parenterální výživa $7 D010288
650    _2
$a nádory žaludku $x komplikace $7 D013274
650    _2
$a setrvalá virologická odpověď $7 D000072230
650    _2
$a výsledek terapie $7 D016896
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jerhotová, Zdeňka $u 1 Infectious Diseases Department, České Budějovice Hospital, České Budějovice, Czech Republic.
700    1_
$a Vacík, Michal $u 3 Gastroenterology Department, České Budějovice Hospital, České Budějovice, Czech Republic.
700    1_
$a Linka, Marek $u 4 National Reference Laboratory for HIV/AIDS, National Institute of Public Health, Prague, Czech Republic.
700    1_
$a Chmelík, Václav $u 1 Infectious Diseases Department, České Budějovice Hospital, České Budějovice, Czech Republic.
773    0_
$w MED00002375 $t International journal of STD & AIDS $x 1758-1052 $g Roč. 30, č. 1 (2019), s. 94-98
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30231834 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20201104105729 $b ABA008
999    __
$a ok $b bmc $g 1451673 $s 1073563
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 30 $c 1 $d 94-98 $e 20180919 $i 1758-1052 $m International journal of STD & AIDS $n Int J STD AIDS $x MED00002375
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...